Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F4ZAC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,092
Award facts
- Contract value 100% obligated
- $10,091.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL quantities, with a ceiling value of $10,091.84. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively awarded. The order is scheduled for completion by November 25, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for the Department of Defense and other federal healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has established itself as a critical vendor for federal medical procurement through its extensive portfolio of brand-name and generic medications, vaccines, and medical supplies. The company's federal contract awards with the DLA Medical Supply Chain demonstrate consistent capability in fulfilling competitive federal procurement requirements across multiple therapeutic domains, including diabetes medications such as Ozempic and other specialty pharmaceuticals. The DLA Troop Support is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen to continue serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible and comprehensive contract vehicles.
Quick answers
Who was awarded contract SPE2DR26F4ZAC?
SPE2DR26F4ZAC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26F4ZAC worth?
The government has obligated $10,092 on SPE2DR26F4ZAC.
Is contract SPE2DR26F4ZAC an order under another contract?
Yes. SPE2DR26F4ZAC is a delivery order under SPE2DR25D2010, an indefinite delivery contract.
Was contract SPE2DR26F4ZAC competed?
The extent of competition for SPE2DR26F4ZAC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award